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of multi-class primary resistance was 1,5% 2005—2006, and
2,6% 2007. K103N was detected as a minority viral quasis-
pecies in 8/224 patients (3,6%), and M184V in 1/68 patients
(1,5%). When these variants were considered, primary resis-
tance rose to 16.9% (6,4%,NRTIs; 8,5%, NNRTIs).
Conclusions: primary resistance to antiretrovirals in the
South East of Spain has been estimated in 11% thorugh the
years 2005—2007. K103N and M184V are present as minority
variants in the newly diagnosed patients of our cohort. No
signiﬁcant changes in trasmitted drug resistance during the
study period have been detected.
doi:10.1016/j.ijid.2008.05.391
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Perception of HIV/AIDS Patients Among Pre-Clinical Dental
Students
H. Oboro ∗, C. Azodo ∗, M. Sede
University of Benin Teaching Hospital, Benin, Nigeria
Aim: The aim of this study is to determine the atti-
tude, knowledge and the willingness of preclinical dental
students to treat patients with Human Immunodeﬁciency
Virus/Acquired Immune Deﬁciency Syndrome (HIV/AIDS) in
the future.
Method: The participants were students of both gen-
ders drawn from the third and fourth year dental classes
of the University of Benin Dental School, Nigeria. One hun-
dred and ﬁfty questionnaires were self-administered, with
92.6% retrieval. The parameters measured were knowledge
and status of HIV/AIDS, immunization against hepatitis B,
willingness to treat HIV/AIDS patients, Knowledge of post
exposure prophylaxis (PEP) and the University of Benin
Teaching hospital (UBTH) protocol for PEP.
Results: Data analysis showed that 71.9% of students
rated their knowledge of HIV/AIDS as either high or very
high. 45.3% thought HIV was a contagious disease while
33.1% felt it was more infectious than tuberculosis or any
of the strains of hepatitis. Only 42.4% of the study popu-
lation knew their HIV status. 91.4% felt professional oral
health care will be beneﬁcial to HIV/AIDS patients. A total of
ﬁfty-one students averred that they would not in the future
administer care to HIV/AIDS patients. Only 28.8% had been
immunized against Hepatitis B. About one in every two stu-
dents studied had no knowledge of PEP while 87.8% did not
know the protocol of PEP in UBTH.
Conclusion: Although a large number of these students
claim to be knowledgeable about HIV/AIDS; it is obvious
from this study, that they lack a true understanding of the
condition. There is therefore an urgent need to properly
inform and education preclinical dental student about the
disease condition, if we hope to totally eliminate the dis-
crimination faced by patients in the hands of healthcare
givers in the near future.
doi:10.1016/j.ijid.2008.05.392
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Seroprevalence of HIV Among Antenatal Cases and
Response to Nevirapine Therapy in Suburban Population
M. Khandait
Pad. Dr. D. Y. Patil Medical college, Pimpri, Pune, India
Background & Objectives: With 27million pregnancies
and with the current prevalence of HIV infection among
pregnant women in India, an estimated 100,000 HIV infected
women deliver every year. The number of HIV-positive
women is increasing, and with it the number of babies with
HIV infection. So this study was carried out to ﬁnd out
the prevalence of HIV in antenatal cases (ANC’s) attend-
ing PPTCT (Prevention of parent to child transmission)
programme and response to nevirapine therapy in HIV
seropositive patients at Pad. DR. D. Y. Patil Medical College
and Hospital, Pimpri, Pune.
Material & Methods: A total of 5775 serum samples were
collected from ANC’s between August 2006 to August 2007
and screened for HIV-1 & HIV2. Samples were tested using
Rapid test kits like Tri-dot, Immuno-comb and Retroscreen
supplied by NACO. All the reactive sera were further tested
and conﬁrmed as per NACO guidelines. Nevirapine was given
to HIV positive mothers and their babies as per NACO guide-
lines. Blood samples were screened for anti-HIV antibody
from Nevirapine received babies after 18 months.
Result: The overall prevalence of HIV infection in ANC’s
was found to be o.81% (47/5775). Out of 47 cases 38 moth-
ers and their babies were received Nevirapine. Seven babies
were lost to follow up and 31 babies were HIV seronegative.
Conclusion: In order to reduce the incidence of antenatal
cases and pediatric HIV infection there should be consis-
tently available drug supplies and services for better and
cost effective coverage. So developing and implementing a
comprehensive PPTCT program in our country is the need of
hour.
doi:10.1016/j.ijid.2008.05.393
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How do AIDS-Deﬁning Illnesses affect the Survival of AIDS
Patients?
S.H. Tey ∗, L.W. Ang
Ministry of Health, Singapore
Background: This study examines the survival of AIDS
patients based on their AIDS-deﬁning illnesses, for the pur-
pose of evaluating the use of AIDS-deﬁning illness as a factor
in the assessment, prognostication and management of AIDS
patients.
Methods: The prognosis of AIDS patients is known to
exhibit varied differences. To describe the survival pat-
tern of patients with AIDS-deﬁning illnesses, we ranked the
median survival time of patients ﬁrst diagnosed as AIDS by
their AIDS-deﬁning illnesses, and adjusted for potential con-
founders in the analyses.
Our retrospective study is based on 1077 patients whose
ﬁrst diagnosis was AIDS in Singapore from 1987 to 2006. We
used Kaplan-Meier estimation of median survival to carry out
the ranking of AIDS-deﬁning illnesses. Cox proportional haz-
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ards models were then used to determine the mortality risk
of the AIDS-deﬁning illnesses before and after adjustment
for potential confounders. The relative hazards of death
were then ranked to check for consistency of ﬁndings. The
analysis was ﬁrst carried out for all AIDS-deﬁning illnesses,
and repeated so as to compare the survival of initial AIDS-
deﬁning illness diagnosed at the time of AIDS diagnosis, and
those diagnosed thereafter.
Results: The results showed poor median survival for
patients with AIDS-deﬁning illnesses of HIV encephalopathy,
unspeciﬁed pneumonias, Lymphoma and Kaposi’s Sarcoma.
The hazard ratios in the multivariate models for each of
these AIDS-deﬁning illnesses were signiﬁcantly higher than
2. The ranking of AIDS-deﬁning illnesses in terms of sur-
vival pattern was noted to be generally consistent even after
adjusting for prognostic factors such as age at diagnosis of
AIDS and number of AIDS-deﬁning illnesses.
Conclusion: We ranked AIDS-deﬁning illnesses according
to adjusted hazard ratios, which showed that clear rank-
ing had been generally maintained. This study serves as an
important reference in evaluating the use of AIDS-deﬁning
illness for assessment, prognostication and management of
AIDS patients.
doi:10.1016/j.ijid.2008.05.394
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The History of HIV/AIDS in Southeast Asia as Reﬂected in
the Us Census Bureau Databases
W.X. Shandera
Baylor College of Medicine, Houston, TX, USA
Purpose: To provide a summary of the trends of HIV infec-
tion among the nations of Southeast Asia.
Methods: The US Census Bureau compiled databases
(December 2006 version) were analyzed for the nations of
Southeast Asia. Linear trends established by regression were
compared by risk factor status through time.
Findings: Data from 11 nations were analyzed ranging
from 39,702 studies in Thailand to 5 in East Timor. Mean
HIV prevalences among all studies were highest in Cambodia
(11.1), Myanmar (10.7) and Thailand (10.2). Among the gen-
eral population, highest prevalences were seen in Cambodia
(3.02) and Thailand (1.74). Linear trends showed highest val-
ues for Viet Nam and Malaysia (both 0.96), although with
sample size weighing the highest was for Cambodia (0.75).
Risk factor groups with highest overall prevalence (exclud-
ing hemophiliacs) were drug using populations in Myanmar
(54.3), Thailand (35.2), Viet Nam (26.0), Indonesia (25.7),
and Malaysia (16.98), and commercial sex workers (CSW) in
Cambodia (27.3), Myanmar (18.8), and Thailand (13.4). In
Thailand, HIV prevalence increased signiﬁcantly among TB
patients (25.8 to 42.1) but fell among CSWs (16.5 to 10.3).
Using linear trend regression analysis, greatest increases
in prevalence were seen among drug using populations in
Indonesia (3.9) and Viet Nam (2.44) and among sexually
treated infection patients in Cambodia (2.3). Decreases in
HIV prevalence were seen among CSW populations in Cam-
bodia (−1.01) and Thailand post-1997 (−1.18). Linear trends
by regression among heterosexually acquired HIV were high-
est in Myanmar (2.13) and the Thai outbreak pre-1998 (1.61).
Conclusions: The HIV epidemic impacts selected popula-
tions in different nations in Southeast Asia. Signiﬁcant gains
in Thailand post-1998 are not shared throughout the region
with rises in prevalence among drug using populations in
Indonesia and Viet Nam. Decreases among CSW populations
in Cambodia are not reﬂected among the trends seen in
Cambodian STI clinics.
doi:10.1016/j.ijid.2008.05.395
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The Changing Epidemiology Among Drug Users in South-
east Asia
W.X. Shandera
Baylor College of Medicine, Houston, TX, USA
Purpose: To provide an analysis of HIV cases among the
drug using populations in the nations of Southeast Asia.
Methods: The US Census Bureau compiled databases
(December 2006 version) for HIV among drug using popula-
tions were analyzed for the nations of Southeast Asia. Linear
and quadratic models were formed and compared by risk
factor status.
Findings: Signiﬁcant data were available for 6 of the
11 nations of SE Asia (Brunei, Cambodia, East Timor, Laos
and Singapore are not represented). The compiled studies
included signiﬁcant numbers from Thailand (1002), Viet Nam
(308), Myanmar (140), Malaysia (65), the Philippines (52)
and Indonesia (36). The overall prevalences for HIV in the
drug-using populations were highest for Myanmar (54.3) and
Thailand (32.5 before 1998, 35.2 1998 and later) and Indone-
sia (25.7) followed by Viet Nam (20.0) and Malaysia (12.1).
The compiled rate was very low for the Philippines (0.07
with 1.6 the highest reported prevalence). The linear trends
obtained as a measure on linear regression showed the high-
est values for Indonesia (3.9 where 21 of 36 studies are from
Jakarta and all Jakarta studies are 1995 or later) followed by
Viet Nam (2.44), Thailand before 1998 (1.72), and Malaysia
(1.3) and Thailand 1998 and later (1.10), Decreasing values
(showing falling prevalence among studies) were reported
from Myanmar (with a high baseline) (−0.28) and the Philip-
pines (−0.007). Quadratic best-ﬁt curves for Malaysia and
Indonesia are shown below.
Conclusions: Advances in HIV/AIDS control among drug-
using populations in Southeast Asia are not uniform. The
nation most impacted is Myanmar and its high prevalences
are associated with some modest decline in recent stud-
ies. The recent upsurge in Indonesia is primarily in Jakarta.
Nations not reporting data require additional surveillance
for the geographically abut the above impacted nations.
doi:10.1016/j.ijid.2008.05.396
